Clinical Trials Directory

Trials / Unknown

UnknownNCT05871502

Glycemia and Ischemia Reperfusion Brain Injury in Patients With Acute Cerebral Infarction Treated With Mechanical Thrombectomy

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Instituto de Investigación Hospital Universitario La Paz · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Postictus hyperglycemia is associated with an accelerated transformation of the ischemic penumbra into an infarct area, with increased infarct size, worse recanalization, reduced cerebral perfusion, increased ischemia reperfusion damage, and worse outcome. Furthermore, when perfusion is reinstated, hyperglycemia causes secondary tissue damage through an increase in ischemic reperfusion damage. Thus, those patients with glycemia values \< 155 mg/dL during mechanical thrombectomy, and especially at the time of reperfusion, will have greater ischemia-reperfusion damage, showing a different profile in miRNA expression, with better neurological and functional outcomes and higher risk of hemorrhagic transformation and cerebral edema. The main objective of the study is to evaluate the association between glycemia values at the time of reperfusion and stroke recovery at 3 months in patients with acute cerebral infarction treated with mechanical thrombectomy.

Conditions

Interventions

TypeNameDescription
DEVICESubcutaneous blood glucose monitoring deviceAfter signing the informed consent and before the start of the endovascular procedure, a subcutaneous blood glucose monitoring device will be implanted, which will be removed on day 15 (or at hospital discharge if this takes place before 15 days). This device will be selected from those currently available on the market, with CE marking, and with previous studies documenting its safety and feasibility for radiological procedures.

Timeline

Start date
2023-04-13
Primary completion
2025-04-13
Completion
2025-04-13
First posted
2023-05-23
Last updated
2023-05-23

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT05871502. Inclusion in this directory is not an endorsement.